Search Results

You are looking at 1 - 1 of 1 items for

  • Author: R Magnaterra x
  • Refine by access: All content x
Clear All Modify Search
R Magnaterra
Search for other papers by R Magnaterra in
Google Scholar
PubMed
Close
,
O Porzio
Search for other papers by O Porzio in
Google Scholar
PubMed
Close
,
F Piemonte
Search for other papers by F Piemonte in
Google Scholar
PubMed
Close
,
A Bertoli
Search for other papers by A Bertoli in
Google Scholar
PubMed
Close
,
G Sesti
Search for other papers by G Sesti in
Google Scholar
PubMed
Close
,
D Lauro
Search for other papers by D Lauro in
Google Scholar
PubMed
Close
,
LN Marlier
Search for other papers by LN Marlier in
Google Scholar
PubMed
Close
,
G Federici
Search for other papers by G Federici in
Google Scholar
PubMed
Close
, and
P Borboni
Search for other papers by P Borboni in
Google Scholar
PubMed
Close

Pregnancy is associated with adaptive changes including increased number and size of beta cells and enhanced gap-junctional coupling among beta cells, increased glucose-induced insulin response and decreased glucose stimulation threshold. The role exerted by pregnancy steroids and lactogenic hormones in the development of islets upregulation during pregnancy has been widely investigated. In the present study we studied the possibility that pregnancy steroids induce functional modifications of beta cells involving the expression and function of glucokinase. Our results indicate that estradiol and progesterone do not influence significantly glucokinase mRNA expression, while they induce a dose-dependent and time-dependent increase of glucokinase activity in RIN 1046-38 cells. The increased enzymatic activity results in an increased glucose-induced insulin release. Therefore it is possible to hypothesize that pregnancy steroids influence glucokinase expression in beta cells at a post-transcriptional level and that this effect contributes to the development of hyperinsulinemia during pregnancy.

Restricted access